Operating identity
Freedom Diagnostics Testing lists 133 Holiday Ct, Suite 106, Franklin, Tennessee and says it was established in 2023. Kris Ryan identifies himself in interviews as one of the owners and describes about 15 years of laboratory experience; those claims were not reconciled to a public legal entity. Issued COAs name Stephen Schmidt and later Alex Johnson as principal chemists, but issuer-hosted biographies were not located.
Operating history and strongest evidence
A fixed Franklin intake address, public methods and pricing, detailed staff interviews, a record-specific certificate registry with 62,278 report files indexed on September 3, and a recurring corpus of issued COAs.
Accreditation scope
The company says it follows ISO 9001 quality-management and GLP principles. Those statements are not an ISO/IEC 17025 laboratory accreditation, and no issuer certificate and scope naming Freedom was located.
Methods and intake
Freedom states that every COA combines HPLC-UV purity with LC-MS identity. Its intake form also offers net peptide content, endotoxin, conformity, and other add-on panels, with a current advertised two-to-four-business-day average turnaround. A September 2025 interview describes intake scanning, sample tracking, replicates, separate endotoxin vials, and publication to the customer portal; its older 24-to-48-hour target is historical, not the current service promise.
Public service record
Recent Reddit threads contain favorable communication and turnaround anecdotes alongside serious disputed dry-labbing allegations. The threads do not resolve those allegations and are not a substitute for method or proficiency evidence.
Important limits
Legal entity, ownership, staff qualifications, accreditation, and disputed analytical-performance claims remain unresolved; file volume is not measurement-performance evidence. The operating-history claim and service claims are primarily first-party. Community allegations are presented only as attributed, unresolved reports.
Additional operating evidence
Freedom Diagnostics Testing says it has operated from Franklin, Tennessee since 2023. Its published workflow combines HPLC purity analysis with mass-spectrometry identity confirmation, while net peptide content, endotoxin, sterility, heavy-metal, and conformity testing depend on the ordered scope.
Verification context
The public lookup accepts a printed Search Code, accession number, or company name. Search Code is the strongest human-facing input because the laboratory explains where it appears and how it is formed; exact official PDFs are stronger destinations than a populated generic search page.
An observable Franklin testing operation
Freedom publishes a Franklin, Tennessee address, a current intake form, pricing, methods, turnaround, and a large official COA repository. Interviews identify Kris Ryan as one of the owners and describe the intake and review workflow, while issued certificates name principal chemists Stephen Schmidt and Alex Johnson. Those are strong signs of an active service, although a legal suffix and primary ownership record remain unconfirmed.
The company says it was established in 2023, while the current domain was registered in February 2025. That difference can reflect a prior offline or differently branded operation and is not evidence against the claim, but independent public substantiation of the earlier start date was not located.
The CLIA credential attached to the wrong Freedom
Several directories attribute CLIA number 14D2263999 to the Franklin peptide lab. That credential resolves instead to Freedom Diagnostic Testing, PLLC in Hillsboro, Illinois, associated with Sara Beth Duff and a waived clinical collection operation. The Tennessee lab's own site and reviewed COAs do not publish that number.
Unless Freedom documents corporate continuity, the Illinois credential must not be used to describe the Tennessee operation as CLIA-certified. Freedom's statements about ISO 9001 quality-management and GLP principles are also not ISO/IEC 17025 accreditation, and no peptide-testing certificate and scope naming the Franklin operation was located.
Methods, prices, and certificate controls
Freedom states that its standard certificate combines HPLC-UV purity with LC-MS identity. Its May 2026 intake form lists purity and identity at $200, net content as a $25 add-on, endotoxin at $175, PCR sterility at $150, conformity testing at $50 per additional vial, and fentanyl screening at $40. The homepage advertises an average two-to-four-business-day turnaround.
The verifier accepts a Search Code, a 10-digit accession number, or an exact company name. A successful match reaches a record-specific official PDF. Search Code combines the first four characters of the submitted company name with the accession number; when an accession maps to more than one file, the complete code is required. The identifier should remain copyable wherever PeptidePrices presents the report.
Scale and the unresolved performance debate
Freedom's report storage exposed 62,278 file keys on September 3, 2026 while the homepage displayed 42,378-plus COAs. That makes the official homepage counter materially stale, but a file-key count is an operating-footprint measure—not proof that every file is unique or every assay is accurate.
Public discussion contains favorable reports about speed and cross-lab agreement alongside dry-labbing allegations, questions about unusually frequent passing results, and complaints about endotoxin interpretation. No regulator finding or controlled proficiency study resolving those claims surfaced. PeptideCritic's profile is also stale on current pricing and publication policy, so its alleged blind-identification failure should remain an attributed, unresolved claim unless the underlying records become available.